CART ITEM (0)
report cover

Prostate Cancer Treatment Drugs Market, Global Outlook and Forecast 2023-2030

  • 11 December 2023
  • Life Sciences
  • 62 Pages
  • Report code : 24WT-7873660
sample cover   Download Free PDF sample

Prostate Cancer Treatment Drugs and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Treatment Drugs Overall Market Size
2.1 Global Prostate Cancer Treatment Drugs Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Treatment Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Treatment Drugs Players in Global Market
3.2 Top Global Prostate Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Treatment Drugs Market Size Markets, 2022 & 2030
4.1.2 Zytiga
4.1.3 Gonax
4.1.4 Lupron
4.1.5 Zoladex
4.1.6 Decapeptyl
4.1.7 Eligard
4.1.8 Vantas
4.1.9 Casodex
4.1.10 Others
4.2 By Type - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
4.2.3 By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Treatment Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Clinics
5.2 By Application - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
5.2.3 By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Treatment Drugs Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2024-2030
6.2.3 By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.3.2 US Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.3 France Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.5.2 China Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.5.6 India Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Treatment Drugs Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Treatment Drugs Market Size, 2018-2030
7 Prostate Cancer Treatment Drugs Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Astella
7.2.1 Astella Company Summary
7.2.2 Astella Business Overview
7.2.3 Astella Prostate Cancer Treatment Drugs Major Product Offerings
7.2.4 Astella Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Astella Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prostate Cancer Treatment Drugs Major Product Offerings
7.3.4 Sanofi Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Ipsen
7.4.1 Ipsen Company Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Prostate Cancer Treatment Drugs Major Product Offerings
7.4.4 Ipsen Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Ipsen Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Prostate Cancer Treatment Drugs Major Product Offerings
7.5.4 Bayer Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Treatment Drugs Major Product Offerings
7.6.4 AstraZeneca Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Dendreon
7.7.1 Dendreon Company Summary
7.7.2 Dendreon Business Overview
7.7.3 Dendreon Prostate Cancer Treatment Drugs Major Product Offerings
7.7.4 Dendreon Prostate Cancer Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Dendreon Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Prostate Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Treatment Drugs Market Drivers in Global Market
Table 3. Prostate Cancer Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Treatment Drugs in Global Market
Table 5. Top Prostate Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Prostate Cancer Treatment Drugs Product Offerings
Table 32. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Astella Company Summary
Table 35. Astella Prostate Cancer Treatment Drugs Product Offerings
Table 36. Astella Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Astella Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Prostate Cancer Treatment Drugs Product Offerings
Table 40. Sanofi Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Ipsen Company Summary
Table 43. Ipsen Prostate Cancer Treatment Drugs Product Offerings
Table 44. Ipsen Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Ipsen Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Prostate Cancer Treatment Drugs Product Offerings
Table 48. Bayer Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Prostate Cancer Treatment Drugs Product Offerings
Table 52. AstraZeneca Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Dendreon Company Summary
Table 55. Dendreon Prostate Cancer Treatment Drugs Product Offerings
Table 56. Dendreon Prostate Cancer Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Dendreon Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Treatment Drugs Segment by Type in 2022
Figure 2. Prostate Cancer Treatment Drugs Segment by Application in 2022
Figure 3. Global Prostate Cancer Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Treatment Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Treatment Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 16. US Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 28. China Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astella Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Ipsen Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dendreon Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

User License

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

Delivery Time

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

Payment Options

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

Report Delivery

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SIMILAR REPORTS


SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
  • Toshiba
  • yamaha
  • nest
  • hp
  • campbell
  • Deloitte
  • Panasonic
  • sit-group
  • Spirax-Sarco
  • Chevron
  • Zeiss
  • showa denko
  • rolandberger
  • valens
  • harris1
  • mckinsey
  • perkinscoie
  • Saviola
  • gelita
  • Allocatesoft
  • siva-group
  • Chevron
  • Zeiss
  • showa denko
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Prostate Cancer Treatment Drugs and Forecast Market

Leave This Empty: